GlassScriptPhysician profile
Darran Kim
NPI 1629570908
$1,801.81
in general payments reported to CMS, 2019-2025
14 companies · $448 in 2025
The $448 reported for 2025 was more than what a typical Optometrist provider received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $574 · 2020: $119 · 2022: $42.29 · 2023: $386 · 2024: $233 · 2025: $448.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $995 · Entertainment: $71.46.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $995.07 |
| Entertainment | $71.46 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bausch & Lomb, A Division of Bausch Health US, LLC | $460.48 | 2019-2020 | |
| Alcon Vision LLC | $319.39 | 2023-2025 | Dailies, Dailies Total1 |
| Biotissue Holdings INC. | $266.68 | 2025 | |
| Coopervision INC. | $182.71 | 2020-2025 | Misight Contact Lens, Clariti Contact Lens, Myday Contact Lens |
| Aerie Pharmaceuticals, INC. | $125.00 | 2019 | |
| Johnson & Johnson Vision Care, INC. | $94.88 | 2019 | |
| Sun Pharmaceutical Industries INC. | $85.49 | 2023-2024 | Cequa |
| Optos, INC. | $71.46 | 2025 | Panoramic Ophthalmoscope, Oct Ophthalmoscope, Nfc-700 |
| Johnson & Johnson Surgical Vision, INC. | $52.14 | 2022-2023 | Lipiflow System Activator (Disposable) |
| Bausch & Lomb Americas INC. | $35.22 | 2024 | Miebo |
| Oyster Point Pharma, INC. | $32.12 | 2022-2023 | Tyrvaya |
| Dompe US, INC. | $31.40 | 2024 | Oxervate |
| Lkc Technologies, INC. | $24.75 | 2025 | |
| Tarsus Pharmaceuticals, INC. | $20.09 | 2024 | Xdemvy |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Darran Kim listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.